Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
NRXN2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SLC22A12 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RASGRP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PYGM - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC22A11 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MAP4K2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC100996455 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
RPS6KA4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CCDC88B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PRDX5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TRMT112 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on